2026 USA Boston BioProcess International Conference & Exhibition

The 2026 BioProcess International Conference & Exhibition (BPI) in Boston, USA, is one of the most influential and largest annual events in the global biopharmaceutical field. Held annually at the Boston Convention and Exhibition Center, it brings together biopharmaceutical industry leaders, scientists, engineers, researchers, and suppliers from around the world. The BPI conference is renowned for its deep industry roots and forward-looking agenda, dedicated to promoting bioprocess innovation, optimizing production processes, and accelerating the research, development, and market launch of biopharmaceuticals. The exhibition has a long history, and over the years, it has developed into the preferred platform for knowledge exchange, technology display, and business cooperation in the bioprocess field. Its grand scale typically attracts thousands of professional visitors and hundreds of exhibiting companies, including many leading global biopharmaceutical companies, biotechnology startups, equipment manufacturers, service providers, and academic institutions. Through keynote speeches, specialized seminars, technical demonstrations, and interactive exhibitions, the BPI conference provides attendees with an excellent opportunity to gain a comprehensive understanding of the latest industry trends, acquire cutting-edge technical information, and expand professional networks. The exhibition's influence is not only reflected in promoting technological progress and business cooperation but also in its leading role in guiding the development direction of the global biopharmaceutical industry. Key exhibiting groups cover all aspects of the biopharmaceutical value chain, from upstream cell culture and fermentation technology to midstream purification and separation processes, and downstream formulation filling and quality control, encompassing everything. Whether it's R&D personnel seeking breakthrough solutions, process engineers hoping to improve production efficiency, or business decision-makers looking for potential partners, the BPI conference offers abundant resources and value.

The 2026 BioProcess International Conference & Exhibition in Boston, USA, features an extremely wide range of exhibits, covering all critical aspects and latest technologies of biopharmaceutical processes. Specific exhibit categories include, but are not limited to: bioreactors and fermenters: various scales and types of bioreactors, such as single-use bioreactors, stainless steel bioreactors, photobioreactors, cell culture tanks, fermenters, and related control systems and accessories. Cell culture and media: cell line development, cell culture media (serum-free media, customized media), fed-batch strategies, cell line engineering, cell cryopreservation technology, cell culture consumables. Separation and purification technologies: chromatography systems (affinity chromatography, ion exchange chromatography, hydrophobic interaction chromatography, etc.), filtration systems (ultrafiltration, microfiltration, nanofiltration, depth filtration), centrifuges, membrane separation technology, virus removal technology, protein purification equipment and reagents. Process Analytical Technology (PAT): online/offline analytical instruments, sensors, spectrometers, chromatographs, mass spectrometers, biosensors, process monitoring and control systems, data analysis and management software. Biopharmaceutical filling and packaging: aseptic filling equipment, lyophilizers, pre-filled syringes, vials, ampoules, packaging materials, cold chain logistics solutions. Quality control and testing: microbial testing, endotoxin testing, mycoplasma testing, virus testing, protein analysis, nucleic acid analysis, cell viability testing, quality control software, regulatory compliance and validation services. Bioprocess services and solutions: Contract Development and Manufacturing Organizations (CDMO/CRO), process development and optimization services, scale-up production services, technology transfer, consulting services, bioinformatics, artificial intelligence and machine learning applications in bioprocessing. Biopharmaceutical equipment and consumables: pumps, valves, piping, connectors, sensors, filters, single-use technology (SUT) products, laboratory equipment, safety protection equipment. Gene and cell therapy processes: viral vector production, cell expansion, gene editing technology, CAR-T cell therapy manufacturing processes, stem cell technology, related equipment and reagents. Digitalization and automation: industrial automation systems, SCADA systems, MES systems, data integrity, smart manufacturing solutions, robotics in bioprocessing. These exhibits collectively form the complete biopharmaceutical industry chain from R&D to production, providing attendees with opportunities for comprehensive understanding and procurement of the latest technologies and products.

No fee information available. Please contact us for a quote.